Xiong, Yi-Ying <br/><br/>
Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Feb 2014 
 - 236-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2013.11.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Chimerism<br/>Female<br/>Fetal Blood--cytology<br/>Graft Rejection--immunology<br/>Graft Survival--immunology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Male<br/>Mesenchymal Stem Cell Transplantation--adverse effects<br/>Mesenchymal Stem Cells<br/>Middle Aged<br/>Prospective Studies<br/>Transplantation, Autologous--adverse effects<br/>Young Adult